Related Experiment Video
Updated: Jul 4, 2026
08:30
Glaucoma-inducing Procedure in an In Vivo Rat Model and Whole-mount Retina Preparation
Published on: March 12, 2016
[Noncompliance with drug therapy for glaucoma]
Aldemar Nemesio Brandão Vilela de Castro1, Wander Araújo Mesquita
1Clínica Oftalmológica do Hospital Israel Pinheiro, Instituto de Previdência dos Servidores de Minas Gerais, Belo Horizonte, MG, Brasil.
Arquivos Brasileiros De Oftalmologia
|June 3, 2008
Summary
Over one-fifth of glaucoma patients show noncompliance with eyedrop treatment. Financial constraints and corrective surgery significantly contribute to this issue, highlighting a need for better patient support and medication accessibility.
Area of Science:
- Ophthalmology
- Pharmacology
- Public Health
Context:
- Glaucoma treatment primarily relies on eyedrops to reduce intraocular pressure and prevent optic nerve damage.
- Patient noncompliance with medication regimens is a significant challenge in managing chronic conditions like glaucoma.
- Factors influencing noncompliance can be multifaceted, involving patient-related, physician-related, and medication-related aspects.
Purpose:
- To determine the prevalence of noncompliance with antiglaucoma eyedrop therapy.
- To identify specific factors contributing to treatment noncompliance in glaucoma patients.
Summary:
- A cross-sectional study involving 102 glaucoma patients was conducted using questionnaires.
- The study found a noncompliance rate of 21.5% among glaucoma patients undergoing eyedrop treatment.
- Key factors significantly associated with noncompliance included financial difficulties in obtaining eyedrops and undergoing corrective eye surgery.
Impact:
- Findings underscore the substantial rate of noncompliance in glaucoma pharmacotherapy.
- Interventions such as providing free eyedrops for economically disadvantaged patients and addressing medication costs are crucial.
- Educational initiatives regarding continued eyedrop use post-surgery are recommended to improve adherence and long-term outcomes.
Related Concept Videos
01:27Open Angle Glaucoma: Treatment
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
01:25Glaucoma: Overview
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
01:28Angle Closure Glaucoma: Treatment
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
01:23Ophthalmic Drug Delivery Systems
Ophthalmic drug delivery faces major limitations due to poor absorption across the corneal membrane. This process is primarily driven by diffusion and is influenced by two main factors: the physicochemical properties of the drug and tear drainage. Most ophthalmic drugs, such as pilocarpine, epinephrine, atropine, and local anesthetics, are weak bases. They are typically formulated at an acidic pH to enhance chemical stability. However, this leads to high ionization, reducing their ability to...
01:28Drug Therapy
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
01:22Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...